Skip to content
Discover expert insights on productivity, mindfulness, and …

Official Reportedly Halted British Hormone Suppressants Study Recused Due to Partiality Claims

An top health figure was recused from oversight in a significant research project on gender-affirming medication following allegations regarding bias emerged.

Alleged Involvement Caused Study Pause

As reported by media coverage, Prof Jacob George, a chief medical director at the medicines regulator, raised worries which caused the pausing of a national research initiative during February.

This agency announced recently that George was recusing him of involvement with the study once questioning social media posts made in the past emerged.

Content Regarding the Online Comments

Among a statement, George referred to author the Harry Potter author being an asset of our time.” Separately, the professor remarked how the refusal of fundamental scientific reality is concerning” in regards to questions about an Olympic athlete’s sex.

The regulator clarified that even though George’s posts were made before his appointment, he had been taken off from involvement with the trial as an preventative measure.

Particulars Regarding the Paused Pathways Study

The research project, which aimed to assess the influence of puberty blockers for children exploring their own gender, was set to start recruiting subjects in the start of the year.

But, the trial was halted during February after the agency raised concerns over the wellbeing for young participants involved.

  • The youngest volunteers were projected to be 10 to 11 among assigned female at birth and eleven to twelve for assigned male at birth.
  • Its research organizers noted at the time that the rigorous screening procedure indicated those enrolled would probably be of a higher age.
  • However, the regulator have since recommended the minimum age threshold ought to be 14 due to an uncertain potential” of lasting health consequences.”

The research aimed to enroll an estimated 226 adolescents during the coming several years.

Context and a Independent Report

The study was commissioned after a recommendation by a major report on youth gender care, which found that the robustness of the evidence suggesting to demonstrate the advantages of this type of medication for adolescents experiencing gender dysphoria were “poor.”

Dr Hilary Cass, who chaired the report, has previously commented the findings exposed a very weak body of research” supporting the benefits of puberty blockers.

She noted, “given that there exist doctors, children as well as families who are convinced passionately in the helpful results, research was the necessary step forward to clarify this.”

Expert Concern of the Decision

Dr Max Davie, an expert in adolescent medicine, stated there was no strong evidence-based justification to suspend the research.

“The tweets from Prof George give a clear indication of his own opinions on the topic,” Dr. Davie said. “He is entitled to possess whatever views on this subject he chooses, but what is unacceptable would be to allow these views to influence the performance of his official role.”

He added: “It must be understood, there exists no persuasive medical basis to stop this study. While the professor’s personal convictions are not the only plausible cause of the MHRA’s abrupt change of position, they is the single factor for which proof.”

Regulator Statement Regarding Next Steps

A regulatory spokesperson said: “With every clinical trials, the MHRA’s primary concern is the protection as well as wellbeing of the volunteers. As part of that commitment, complex studies remain continuously under review and the agency maintains an active discussion with trial sponsors.”

“The MHRA has leading medical, scientific and regulatory specialists that operate in a collaborative team to make scientifically sound rulings on clinical trials. This team are continuing to meet alongside the organizers to work through the next steps productively.”

“Following the finding of social media posts posted before his appointment, Professor Jacob George has been recused of continued participation on the Pathways study as a abundance of caution.”

By

Michael Fox

Alexandra Hartley is a cognitive psychologist and productivity coach who writes about mindful living and effective decision-making.

Focus Insight

Type to search articles.